Year: 2019

UNIONDALE, N.Y., Dec. 09, 2019 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (the “Company”) (NYSE: ABR) announced today that it plans to make a public offering of 6,000,000 shares of its common stock.  In connection with the offering, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 900,000 shares of its common stock.The Company intends to use the net proceeds from the offering to make investments relating to its business and for general corporate purposes. The Company also intends to use a portion of the net proceeds from this offering to purchase an aggregate of 600,000 shares, or 690,000 shares if the underwriters exercise in full their option to purchase additional shares, of the Company’s common stock from its Chief Executive Officer, Arbor Commercial Mortgage, LLC and/or an estate...

NEW YORK, Dec. 09, 2019 (GLOBE NEWSWIRE) — Pzena Investment Management, Inc. (NYSE: PZN) today reported its preliminary assets under management as of November 30, 2019.AUM for month-end November 2019, month-end October 2019, and month-end November 2018 are listed below:Pzena Investment Management, Inc.Assets Under Management1($ billions)1 Numbers may be subject to rounding.About PzenaPzena Investment Management, LLC, the firm’s operating company, is a value-oriented investment management firm.  Founded in 1995, Pzena Investment Management has built a diverse, global client base.  More firm and stock information is posted at www.pzena.com.Forward-Looking StatementsThis press release may contain, in addition to historical information, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,...

LA JOLLA, Calif., Dec. 09, 2019 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for itolizumab for the treatment of lupus nephritis. Equillium initiated the EQUALISE Phase 1b study of itolizumab in patients with lupus and lupus nephritis in September 2019.The FDA’s Fast Track program is designed to facilitate the development of new treatments for serious or life-threatening conditions for which there is a significant unmet medical need. Companies with investigational drugs that receive Fast Track designation benefit from more frequent meetings or communications with the FDA...

Highlights:Accelerates Business Transformation and Aligns with Strategy to Simplify the OrganizationIncreases Focus on Core Higher Margin BusinessesFurther Strengthens Financial Flexibility to Invest in Growth OpportunitiesCHATTANOOGA, Tenn., Dec. 09, 2019 (GLOBE NEWSWIRE) — Astec Industries, Inc. (Nasdaq: ASTE) announced today that it intends to sell its GEFCO, Inc. subsidiary, located in Enid, Oklahoma.  GEFCO produces drilling equipment for water wells, geothermal wells, and cathodic protection; high-pressure double pumpers for energy services; and King Oil Tools for oil & gas and other applications.  The GEFCO businesses contributed approximately $50 million in annualized revenue and the divestiture is expected to eliminate related annual operating losses and be accretive to annualized EPS.  The divestiture process is in...

TORONTO, Dec. 09, 2019 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by TDb Split Corp. please note that in the third paragraph of the release, the Preferred share price and yield have changed.TDb Split Corp. (the “Company”) is pleased to announce it has filed a preliminary short form prospectus in each of the provinces of Canada with respect to an offering of Priority Equity Shares and Class A Shares of the Company. The offering will be co-led by National Bank Financial Inc., CIBC World Markets Inc., Scotia Capital Inc. and will also include a syndicate of dealers.The Priority Equity Shares will be offered at a price of $10.00 per Share to yield 5.25% and the Class A Shares will be offered at a price of $6.15 per Class A Share to yield 9.75%.The closing price on the TSX of each of the Priority Equity...

NASHVILLE, Tenn., Dec. 09, 2019 (GLOBE NEWSWIRE) — Ryman Hospitality Properties, Inc. (NYSE: RHP) (the Company) announced today it has reached an agreement with Stratus Properties Inc. (NASDAQ: STRS) to acquire Block 21, a mixed-use entertainment, lodging, office and retail complex located in the heart of downtown Austin, Texas, for $275 million, which includes the assumption of approximately $141 million of existing mortgage debt.Completed in 2010 and located on an entire city block in Austin’s 2nd Street District, Block 21 is home to the iconic ACL Live at the Moody Theater (ACL Live), a 2,750-seat state-of-the-art entertainment venue that serves as the filming location for the famed Austin City Limits television series. The Block 21 complex also includes the 251-room W Austin Hotel, the 350-seat 3TEN at ACL Live club and approximately...